Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects
Clinical trial NCT05005455 · COMPLETED
Trial details
- NCT number
- NCT05005455
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2022-01-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.